Importantly, in discussing this study’s findings, the authors point out that the 50% reduction in AVP-expressing SCN cells—observed in adults with AD—matches the lesion magnitude required to disrupt circadian rhythms in rodent studies (Van den Pol and Powley, 1979; Pickard and Turek, 1983). This evidence concerns the gene AVP and Alzheimer disease.